OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 146 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $24,000 | -66.7% | 41,930 | 0.0% | 0.00% | – |
| Q4 2015 | $72,000 | -18.2% | 41,930 | 0.0% | 0.00% | – |
| Q3 2015 | $88,000 | -71.2% | 41,930 | -32.3% | 0.00% | -100.0% |
| Q2 2015 | $306,000 | -36.9% | 61,907 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $485,000 | +29.3% | 61,907 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $375,000 | +42.0% | 61,907 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $264,000 | -31.1% | 61,907 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $383,000 | -4.7% | 61,907 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $402,000 | +15.2% | 61,907 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $349,000 | -8.2% | 61,907 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $380,000 | +5.0% | 61,907 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $362,000 | – | 61,907 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,235,000 | $5,261,000 | 5.04% |
| Cheyne Capital Management (UK) LLP | 693,642 | $2,958,000 | 1.05% |
| Rock Springs Capital Management LP | 1,250,000 | $5,325,000 | 0.82% |
| NEA Management Company, LLC | 3,709,000 | $15,800,000 | 0.80% |
| Rhenman & Partners Asset Management AB | 494,000 | $2,104,000 | 0.62% |
| Palo Alto Investors LP | 1,931,324 | $8,227,000 | 0.62% |
| PFM Health Sciences, LP | 4,838,324 | $20,611,000 | 0.47% |
| CQS Cayman LP | 1,750,000 | $7,455,000 | 0.44% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 1,700,371 | $7,243,000 | 0.37% |
| SAMLYN CAPITAL, LLC | 2,299,000 | $9,794,000 | 0.20% |